At a press conference held tonight in Madrid, Health Minister Carolina Darya said that the Spanish Medicines Agency (AEMPS) is investigating two other cases of thrombosis related to the AstraZeneca vaccine.
According to his information, they are looking for an answer as to whether the three Spanish cases known to date developed as a side effect of a vaccine in stroke patients.
As he said, the Coronavirus vaccine developed by the British-Swedish pharmaceutical company AstraZeneca and the University of Oxford has so far received more than 975,000 people in Spain.
The ministry said in a statement that one of them had died of a stroke. According to the Spanish press, she is a 43-year-old teacher from Malaga, who died on Tuesday. He was vaccinated on March 3.
Like many countries, Spain temporarily stopped the use of AstraZeneca on Monday until the European Medicines Agency (EMA) investigation into the relationship between the disease and vaccination was completed. The EMA is expected to announce its results on Thursday.
Carolina Daria It also reported that 7.68 million vaccines have so far arrived in the southern European country from three European licensed companies, of which 5.85 million received the first dose and 1.8 million received the two doses.
The minister said that the pace of the epidemic has slowed, so he asked everyone to be more careful and follow health standards.
During the past 24 hours, three thousand new cases were diagnosed, while the number of registered cases increased by six thousand. Since the outbreak of the epidemic, more than 3.2 million people have been infected with the Coronavirus. Last week, 405 people were killed, and the death toll reached 72,793.
Pedro Sanchez The Spanish prime minister welcomed in a message on Twitter and described the European Commission’s proposal on Wednesday to introduce a European vaccine passport, which Spain supports, as good news.